Actively Recruiting

Age: 5Years - 100Years
All Genders
Healthy Volunteers
ID00943514

Natural History of Bronchiectasis Study to Understand Causes and Progression

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-04-14

900

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying bronchiectasis, a condition where the airways become inflamed, abnormally widened, and chronically infected. This condition often involves repeated infections in the respiratory tract, including sinus, ear, and lung disease. The study aims to understand the natural history of bronchiectasis and identify inherited and immune factors that may explain why some people have repeated infections. The research focuses primarily on bronchiectasis not related to cystic fibrosis, although some comparisons with cystic fibrosis and immune defects may be made. Participants include individuals aged 5 years and older with a diagnosis of bronchiectasis or a history of chronic respiratory infections. Family members of patients may also be invited to participate. The study involves initial clinical evaluations, medical history collection, quality of life and respiratory symptom questionnaires, and standard tests like nose air sampling, imaging (x-rays or CT scans), lung function tests, and collection of blood, urine, and sputum samples. These procedures help researchers study infection susceptibility and disease mechanisms. Participants will be followed at least every 6 months for the first 2 years, then at intervals of 1 to 5 years, for up to 5 years or until they choose to stop. During visits, researchers will monitor disease progression, treatment outcomes, and underlying causes. Samples for genetic testing and further analysis will be collected from patients and relatives. Standard medical care and treatments will continue as needed to prevent infections and disease worsening throughout the study.

CONDITIONS

Brief Title

Natural History of Bronchiectasis

Who Can Participate

Age: 5Years - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Children age 5 years and above and adults referred with chronic or recurring respiratory infections are eligible.
  • Both males and females of any race or ethnicity may participate.
  • Emphasis on non-cystic fibrosis bronchiectasis; select cystic fibrosis or acquired immune defect patients may be included for comparison.
  • Must have a primary or referring physician.
  • Must be willing to have samples stored for research.
  • Blood relatives of patients may also participate without age limits for genetic and host defense studies.
Not Eligible

You will not qualify if you...

  • Participants with common respiratory problems like aeroallergen sensitivity, asthma, or gastric esophageal reflux without underlying host defense defects are excluded.
  • Participants unable or unwilling to provide informed consent.
  • Participants unlikely to comply with regular follow-up or provide pertinent disease information may be excluded.
  • Children under 5 years old are excluded due to difficulties with testing and distinguishing infections in young children.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years or until participants no longer wish to return

Participants are followed to observe the causes, progression, and outcomes of bronchiectasis and related respiratory conditions.

Visits at least every 6 months for the first 2 years, then every 1 to 5 years

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

C

Chevalia J Robinson, R.N.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Cohort for Inflammatory Respiratory Diseases: From Phenoty...

Chronic Obstructive Pulmonary Disease

Actively Recruiting

1 location

A Single Ascending Dose, Phase 1/2 Trial to Evaluate the Saf...

Cystic Fibrosis

Actively Recruiting

4 locations

A Phase 1/2 Study Evaluating Safety, Tolerability, and Biodi...

Cystic Fibrosis

Actively Recruiting

23 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples.

Aleksandra Lunich, Andrea J Radtke, Margaret Williams...

https://pubmed.ncbi.nlm.nih.gov/40720370